Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Workers' Comp
Article
PTSD Presumption Claims are Rising. Workers’ Comp Needs a Stronger Clinical Response
As PTSD presumption laws expand, workers’ compensation teams are facing a more complex challenge: how to support trauma-exposed workers with timely
Workers' Comp
Article
Protect Your Program from Unnecessary Risk: Why Provider Agreements Matter More Than Ever
As new approaches to medical cost containment gain attention, workers’ compensation payers are taking a closer look at what truly creates sustainab
Business Insurance
In the News
Complexities with return to work after violence can be bridged: Panel
Workers' Comp
Article
Specialty Solutions Spotlight: How Adjusters Can Spot CRPS Early in Work Comp Claims
How can I tell when an upper extremity claim is at risk of CRPS?Complex Regional Pain Syndrome, or
Workers' Comp
Podcast
What Really Drives P&C Policy Change: It’s Local
Workers' Comp
Case Study